News

Investors were surely discovering drug discovery company AbCellera Biologics (NASDAQ: ABCL) as the trading week kicked off on ...
The FWC found that the letter of 11 January 2023 constituted a valid contract variation. The Commission stated: "This letter ...
Grundy advises companies to keep communication open, move quickly, and showcase company culture and career growth early in ...
Plans for a 35-metre-high telecoms tower at a Sunderland business park have been submitted to council development bosses.
Studio 17’s Job Corner, in partnership with Cazador Consulting Group, is your go-to resource for career growth. This week, ...
A better regulatory regime would give payments companies access to the Fed’s payment rails without allowing them to take and ...
The tribunal, presided over by Justice V.G. Bisht (Judicial Member) and Prabhat Kumar (Technical Member), was hearing the ...
Less face time with potential hires means firms are increasingly interested in AI-backed tools that predict success.
India's SPMEPCI attracts European and South Korean carmakers, but Tesla shows no interest in 'Make in India' scheme.
The trial will evaluate AXPAXLI in at least 555 patients in a multi-center, double-masked, randomized (2:2:1), 3-arm study.
Eco Wave Power is eyeing a tentative grid-connection date for 2026, pending final permitting, construction, and regulatory ...
CFTC enforcement action settlement that may have introduced a new test for when the Commodity Exchange Act and the agency's regulations ...